New liquid seizure medicine for kids under study

NCT ID NCT06534502

Not yet recruiting Disease control Sponsor: Azurity Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a liquid form of the seizure drug zonisamide in children aged 1 month to 17 years who have partial-onset seizures. The goal is to find the right dose and check for side effects. About 40 children will take the medicine for up to 12 weeks, with a follow-up visit one week later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: zonisamide oral suspension
What this could lead to: If successful, this could provide a child-friendly liquid dose of zonisamide to better control partial-onset seizures in children.
What could go wrong: This is a small Phase 4 study with only 40 children, so results may not apply to all. Side effects are possible, and the drug may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPILEPSIES, PARTIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy focal epilepsy visual epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSIES, PARTIAL EPILEPSY SEIZURE DISORDER, PARTIAL SEIZURE, PARTIAL SEIZURE, PARTIAL ONSET SEIZURES SEIZURES, FOCAL

Contacts and locations

Locations

Le Bonheur Children's Hospital

Memphis, Tennessee, 38103, United States
Wake Forest University School of Medicine

Winston-Salem, North Carolina, 27101, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.